Shionogi Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHIONOGI, and what generic alternatives to SHIONOGI drugs are available?
SHIONOGI has eight approved drugs.
There are four US patents protecting SHIONOGI drugs.
There are seventy-two patent family members on SHIONOGI drugs in thirty-eight countries and thirty-three supplementary protection certificates in sixteen countries.
Drugs and US Patents for Shionogi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shionogi | UROPLUS SS | sulfamethoxazole; trimethoprim | TABLET;ORAL | 071815-001 | Sep 28, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Shionogi Inc | DORIBAX | doripenem | INJECTABLE;INTRAVENOUS | 022106-001 | Oct 12, 2007 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | 9,238,657 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Shionogi | UROPLUS DS | sulfamethoxazole; trimethoprim | TABLET;ORAL | 071816-001 | Sep 28, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-002 | Sep 9, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Shionogi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Shionogi Inc | ULESFIA | benzyl alcohol | LOTION;TOPICAL | 022129-001 | Apr 9, 2009 | 5,858,383 | ⤷ Try a Trial |
Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-003 | Sep 9, 1993 | 4,631,286 | ⤷ Try a Trial |
Shionogi Inc | ULESFIA | benzyl alcohol | LOTION;TOPICAL | 022129-001 | Apr 9, 2009 | 6,793,931 | ⤷ Try a Trial |
Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-002 | Sep 9, 1993 | 4,631,286 | ⤷ Try a Trial |
Shionogi Inc | RYBIX ODT | tramadol hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021693-001 | May 5, 2005 | 5,464,632 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SHIONOGI drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 250 mg/vial and 500 mg/vial | ➤ Subscribe | 2011-10-11 |
➤ Subscribe | Lotion | 5% | ➤ Subscribe | 2016-04-11 |
International Patents for Shionogi Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2010050468 | ⤷ Try a Trial |
Taiwan | I593690 | ⤷ Try a Trial |
France | 20C1050 | ⤷ Try a Trial |
Brazil | 112017004166 | ⤷ Try a Trial |
Taiwan | 201020259 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Shionogi Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0528678 | 09C0005 | France | ⤷ Try a Trial | PRODUCT NAME: DORIPENEME; REGISTRATION NO/DATE IN FRANCE: EU/1/07/467/001 DU 20080725; REGISTRATION NO/DATE AT EEC: EU/1/08/467/001 DU 20080725 |
2960244 | 2020C/541 | Belgium | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROCOL, OPTIONEEL IN DE VORM VAN EEN FARMACEUTISCH ZOUT OF SOLVAAT; AUTHORISATION NUMBER AND DATE: EU/1/20/1434 20200424 |
2960244 | 2020/044 | Ireland | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROCOL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE; NAT REGISTRATION NO/DATE: EU/1/20/1434 20200424; FIRST REGISTRATION NO/DATE: EU/1/20/1434 20200424 |
2960244 | SPC/GB20/053 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROCOL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE; REGISTERED: UK EU/1/20/1434 (NI) 20200424; UK PLGB 50999/0009 20200424 |
2960244 | 2020035 | Norway | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROKOL, EVENTUELT PA FORMEN AV ET FARMASOEYTISK AKSEPTABELT SALT ELLER SOLVAT; REG. NO/DATE: EU/1/20/1434 20200508 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.